BiomeSense
BiomeSense develops an AI-enabled technology platform combining novel hardware and bioinformatics for continuous, low-cost, and longitudinal gut microbiome data generation and analysis. Their flagship products, GutLab and MetaBiome, enable at-home or clinical site microbiome tracking and advanced AI-driven bioinformatics analysis, unlocking new insights into host-microbiome interactions for personalized medicine. The company partners with leading scientists and institutions to support exploratory research, biomarker discovery, and product development in microbiome therapeutics, diagnostics, and probiotics. Their platform offers a scalable, cost-effective solution that generates over 30 times more data with up to 90% cost reduction, positioning BiomeSense as a leader in microbiome precision medicine technology.
BiomeSense
BiomeSense develops an AI-enabled technology platform combining novel hardware and bioinformatics for continuous, low-cost, and longitudinal gut microbiome data generation and analysis. Their flagship products, GutLab and MetaBiome, enable at-home or clinical site microbiome tracking and advanced AI-driven bioinformatics analysis, unlocking new insights into host-microbiome interactions for personalized medicine. The company partners with leading scientists and institutions to support exploratory research, biomarker discovery, and product development in microbiome therapeutics, diagnostics, and probiotics. Their platform offers a scalable, cost-effective solution that generates over 30 times more data with up to 90% cost reduction, positioning BiomeSense as a leader in microbiome precision medicine technology.